Skip to main content

IPPOL30 Management of Group A Streptococcus infection in Community Settings V3

Page 1

IPPOL30

Management of Group A Streptococcus in Community Settings

Page 1 of 21


Version:

V[3]

Ratified by:

Infection Prevention and Control Group

Date ratified:

21/09/2026

Job Title of author:

Specialist infection Prevention and Control Nurse Infection Prevention and Control Group

Reviewed by Committee or Expert Group Equality Impact Assessed by: Related procedural documents

Review date:

Specialist Infection Prevention and Control Nurse IPPOL17 Aseptic Non-Touch Technique Policy IPPOL21 Standard Precautions for Infection Prevention and Control including TBPs and Isolation precautions IPPOL03 Infection Control - Hand Hygiene Policy IPPOL18 Management and Safety of Sharps Policy IPPOL09 Decontamination of Medical Equipment Policy 21/09/2029

It is the responsibility of users to ensure that you are using the most up to date document template – i.e. obtained via the intranet. In developing/reviewing this policy Provide Community has had regard to the principles of the NHS Constitution.

Page 2 of 21


Version Control Sheet Version V1

Date October 2020

Author Infection Prevention Nurse

V2

October 2023

V3

October 2026

Specialist Infection Prevention Nurse Specialist Infection Prevention and Control Nurse

Page 3 of 21

Status New Policy

Comment

Review

Review Revision

and


Contents 1.

Introduction .................................................................................................... 5

2.

Purpose ........................................................................................................ 6

3.

Definitions ...................................................................................................... 6

4.

Duties ............................................................................................................ 7

5.

Consultation and Communication ................................................................ 11

6.

Monitoring .................................................................................................... 11

7.

Infection Prevention and Control .................................................................. 11

8.

Management of cases ................................................................................. 13

9.

Training ....................................................................................................... 14

10.

References .............................................................................................. 14

Appendix 1: Patient information Leaflet................................................................ 15 Appendix 2: Patient information Leaflet................................................................ 17 EQUALITY IMPACT ASSESSMENT TEMPLATE ................................................ 18 Stage 1: ‘Screening’............................................................................................. 18 EQUALITY IMPACT ASSESSMENT TEMPLATE ................................................ 20 Stage 2 ................................................................................................................ 20

Page 4 of 21


1. Introduction Group A Streptococcus (GAS) is a bacterium often found in the throat and on the skin. Strep A is also known as Streptococcus pyogenes. GAS usually causes mild infections such as sore throats or a ‘strep’ throat (tonsillitis). It is also responsible for skin infections such as impetigo, cellulitis and respiratory infections including scarlet fever. GAS bacteria can spread from person to person through contact with respiratory droplets from a person with strep throat. These droplets may spread when a person with strep throat coughs or sneezes. If you are exposed to those droplets, then touch your mouth or rub your eyes you could become infected. The bacteria can also spread as a result of direct contact with an infected individual. Impetigo can be caused by GAS. On rare occasions, GAS, can cause more serious infections. This is called invasive GAS or iGAS. iGAS occurs when the bacterium gets into parts of the body where it is not usually found, such as the muscles, lungs or blood. It does this by getting past the defences of the person who is being infected. This can be through sores or breaks in the skin which allow the bacteria to invade deep into tissues or blood stream. Some strains of GAS are more easily able to cause severe disease than others. Invasive Group A streptococcal (iGAS) infections can cause life-threatening infections such as: • • • • • • •

bacteremia, (blood stream infection) cellulitis pneumonia meningitis puerperal sepsis Septic Arthritis less commonly, necrotizing fasciitis and Streptococcal Toxic Shock Syndrome (STSS)

Two of the most severe, but rare, forms of invasive GAS disease are necrotising fasciitis which is a deep tissue infection with tissue destruction requiring surgery and Streptococcal Toxic Shock Syndrome which is an illness with some of the following: high fever, low blood pressure, confusion, rash as in scarlet fever, diarrhoea and vomiting, difficulty in breathing, kidney or liver damage and blood clotting problems. GAS can cause outbreaks of infection in healthcare settings including community, acute, maternity, residential and nursing home settings. Outbreaks may occur over prolonged, periods of time and can affect patients in a wide geographic area. They can involve spread from colonised staff to patients, patient to patient and as a result of contamination of medical devices, towels and bedding and occasionally via food if prepared by someone with the infection. GAS is usually diagnosed by microbiological culture of the affected site. GAS isolates from patients with healthcare-associated infections should be stored locally for a minimum of 6 months. Page 5 of 21


As with many infections, a person is more vulnerable to GAS if they have a poor or inadequate immune system as their ability to fight infection is impaired. Invasive GAS (iGAS) infection and scarlet fever are both notifiable diseases requiring notification to the local Health Protection Team at UK Health & Security Agency (UKHSA).

2. Purpose The purpose of this policy is to ensure prompt diagnosis and treatment of patients which is essential to reduce the morbidity and mortality associated with all GAS infections

3. Definitions Group A Streptococcal Infections (GAS) Streptococcus pyogenes, also known as (GAS), is the most common bacterium in the streptococcus group. Under a microscope, streptococcus bacteria look like a twisted bunch of round berries. It can cause a multitude of illnesses. GAS infection is illness associated with GAS, it may be clinically likely from signs and symptoms or microbiologically confirmed. with respiratory secretions (mucus) or sores on the skin. GAS infections can cause over 500,000 deaths per year, despite the emergence of antibiotics as a treatment for streptococcus infection. GAS is becoming an increasing problem, with a rapid increase in cases affecting children at the end of 2022 attributed largely to increased socialising post-pandemic.

Invasive Group A Streptococcal Infections (iGAS) Invasive GAS (iGAS) is illness associated with isolation of GAS from blood or a normally sterile site. It also includes severe disease including necrotising fasciitis (NF) or Streptococcal Toxic Shock Syndrome (STSS) where the GAS was isolated from a normally non-sterile site- e.g. skin.

Community Setting Community setting refers to the services Provide CIC provide to patients in their own homes or Residential Home.

Incidence of iGAS An incidence of iGAS refers to one diagnosed case, which must be reported to local Health Protection team.

Outbreak of iGAS An outbreak of iGAS is where there are two or more cases of infection linked by person or place. These cases will usually be within a month of each other, but the interval may Page 6 of 21


extend to six months especially if detected due to typing of isolates over an extended period. Where an outbreak is identified this must be reported to local Health Protection Unit.

Personal Protective Equipment PPE PPE refers to items of equipment that are worn by the healthcare worker to protect from injury, hazardous material or spread of infection. These items include use of aprons/long sleeve gowns, gloves, eye protection such as goggles or visor and types of facial masks. The correct use of PPE can prevent transmission of contaminants from blood, body fluids, or respiratory secretions.

Standard Infection Control Precautions Standard infection control precautions (SICPs) are the basic infection prevention measures necessary to reduce the risk of transmission of infectious agents from both recognised and unrecognised sources of infection. Standard infection control precautions (SICPs) are to be used by all staff, in all care settings, at all times, for all patients whether infection is known to be present or not. This is to ensure the safety of those being cared for, staff and visitors in the care environment.

Carrier of GAS or Group A Streptococcal Carriage An individual who harbors the specific GAS organism without manifestation of symptoms and is capable of transmitting the infection to others; the condition of such an individual is referred to as the ‘carrier’ state or having carriage of Strep A such as throat carriage without symptoms of sore throat or infection. This is the isolation of GAS from a non-sterile site with no symptoms attributable to infection from these bacteria

4. Duties All clinical staff must work within this procedure and be familiar with associated documentation which supports best practice in managing GAS infection and preventing transmission.

The Chief Executive has the responsibility to: •

ensure that infection prevention and control is a core part of clinical governance and patient safety programme.

•

Promote staff compliance with infection prevention policies, procedures in order to prevent Healthcare Associated Infections (HCAI).

•

Awareness of legal responsibilities to identify, assess and control the risk of infection.

Page 7 of 21


Group Chief Nurse and Group Chief Operations Director/Director of Infection Prevention and Control (DIPC) •

Oversee infection prevention policies, procedures, guidance and their implementation.

•

Reports directly to the Chief Executive and Board members.

Infection Prevention and Control Team (IPCT) is responsible for: •

Acting as a resource for best practice for clinical staff, which includes training where required for staff to be familiar with this procedure.

•

Investigating cases of GAS when notified and undertaking appropriate immediate measures to prevent spread of GAS.

•

Alert appropriate clinical and operational staff should a potential outbreak of GAS be detected.

•

If outbreaks of GAS are detected the IPCT will be actively involved as members of the Outbreak Control Team see IPPOL16 Management and control of an Outbreak of infection policy.

Consultant Microbiologists Either working for UKHSA or local laboratories consultant microbiologists are responsible for advising on the provision of appropriate antimicrobial therapy to Clinicians/GP and staff. Consultants may also be members of the Outbreak Control Team.

Assistant Directors •

Support managers by providing resources for implementation of specific measures associated with management of GAS infections.

•

Support managers and infection prevention link practitioners in the auditing and monitoring of levels of compliance with measures that prevent GAS infection and reduce the risk of transmission, i.e. SICP, hand hygiene, decontamination resources such as cleaning of medical equipment, wound care, and cleanliness of environment.

•

To assist managers to ensure that staff have the correct equipment to help prevent the spread of GAS in wound care.

•

To ensure that robust escalation procedures are in place relating to wound deterioration and sepsis.

Line Managers •

Have responsibility for ensuring all staff are up to date with mandatory infection prevention training.

Page 8 of 21


•

To contribute to outbreak investigations, including staff screening and control measures as necessary, such as providing a list of ‘contacts’ when a case of iGAS is known.

•

Ensuring staff with GAS infections are referred to Occupational Health and do not work while potentially infectious. To ensure that staff are proactively swabbing suspected infective wounds and refer to the CGU16 Wound management Clinical Practice Guidelines

•

Managers must ensure that staff have the correct equipment to help prevent the spread of GAS wound infection, these include: 1.Single use Maceratable bowls for leg cleansing and cloths 2. Disposable floor covering for staff to use when kneeling 3. Single use scissors 4. Single use long sleeve plastic aprons 5. Hand disinfectant wipes and hand sanitiser where handwash facilities cannot be accessed in home or location of visit 6. Hand hygiene equipment (alcohol gel and paper towel) 7. Hand wash soap 8. Community Equipment bag or wipeable Plastic car boot box for storage and transport of clinical supplies 9. Sterile dressing packs 10. Doppler leg coverings 11. BP arm coverings 12. Replacement doppler canvas carry cases 13. Detergent/disinfectant wipes 14. Formulary dressings 15. New IT technology to help improve wound management

•

To ensure that robust escalations are in place for the deterioration of wounds and sepsis.

•

To ensure that where a patient has complex wound needs the patient is referred to appropriate services such as Tissue Viability or podiatry.

•

To ensure all infected patients have a HCAI form completed and sent to the IP team.

•

Items of reusable medical equipment must be cleaned after each use. Items used off site i.e. in the patient’s home be thoroughly cleaned weekly in a designated decontamination room in line with IPPOL 09 Decontamination of medical equipment policy.

•

To actively swab suspected/infected wounds and action results.

•

To ensure staff datix results that are not actioned, or if results are not returned within 72hrs-96hrs.

•

To ensure a datix is completed if results are delayed longer than 96hrs.

Page 9 of 21


•

To support managers and infection prevention link practitioners in the auditing and monitoring levels of compliance using the ward with measures that prevent GAS infection and reduce the risk of transmission.

•

To ensure that staff wear correct uniform and have adequate items of uniform (dress/shirt etc.) to enable regular change/laundering.

•

Ensure that staff risk assess the suitability of the patient home environment prior to performing wound care.

•

To ensure that ICT bases are clean.

•

To ensure that office spaces are not used for storing consumables.

•

To ensure that storerooms are cleaned weekly and open supplies are stored in lidded, wipeable containers on shelving and off the floor.

The Occupational Health Service – currently Medigold is responsible for: •

If appropriate or agreed with UKHSA and Provide CIC, Occupational Health are responsible for providing advice to staff about exposure to GAS and providing antimicrobial prophylaxis under appropriate clinical/medical guidance.

•

Investigating and treating staff with known carriage of GAS as referred to by line manager and under appropriate clinical/medical guidance.

•

Contributing to outbreak investigations including staff screening when it is determined to be appropriate.

•

In some circumstance where staff screening is required and occupational health provider cannot accommodate screening, alternative arrangements with external agencies will be made.

UK Health & Security Agency (UKHSA) are responsible for: • Providing advice to contacts of cases of GAS and iGAS in the community. •

Identifying significant contacts of community cases of iGAS. Significant contacts defined as >24hours continuous exposure as this increases risk of GAS colonisation.

•

Contributing to (and on occasions, leading on) outbreak investigations of community GAS.

All Clinical Staff are responsible for: •

Maintaining standards of hygiene and use of Personal Protective Equipment (PPE) for the prevention of transmission of infection.

Page 10 of 21


•

To ensure that if they are known to have GAS infection or are symptomatic with temperature and sore throat or wound infection, they take appropriate measures to seek advice and obtain treatment from their GP.

•

Informing Occupational Health and an appropriate senior manager if aware that they may be infected or colonized with GAS.

•

Contributing to outbreak investigations including cooperating with staff screening and other control measures as necessary.

All clinical staff must work within this procedure and be familiar with associated documentation which supports best practice in managing GAS infection and preventing transmission.

5. Consultation and Communication This policy has been developed by the IP team in consultation with members of the Infection prevention group for comment and approval. In development this policy has been guided by the latest to date national resources available from NHS England, UKHSA and National Institute for health and care excellence (NICE).

6. Monitoring In the event of planned change in the process(es) described within this document either by UKHSA or at local level, or an incident involving the described process(es), this policy will be reviewed and revised as necessary to maintain its accuracy and effectiveness.

7. Infection Prevention and Control GAS is spread by close contact between individuals, through: • •

respiratory droplets direct skin contact

It can also be transmitted environmentally, through: • •

contact with contaminated objects, such as reusable medical equipment, towels or bedding. ingestion of food contaminated by an individual carrier of the bacteria.

Signs and Symptoms of GAS Infection Invasion and presentation of infection occur 1-3 days after initial colonisation and can include the following: • • • •

Tonsillitis, sore throat Pharyngitis Fever Scarlet fever characterised by a rash, red and swollen tongue and flushed cheeks. Page 11 of 21


• • • • •

Impetigo Enlarged lymph nodes in the neck. Rash Cellulitis Pus collections on the tonsils, tiny red spots on the palate, headache, abdominal pain.

Precautions for Prevention of Transmission Hand Hygiene As part of SICP hand hygiene is one of the most important factors in preventing transmission of infection. All HCWs must adhere to Provide hand hygiene policy. On identification of patient with GAS infection, it is also important to assist and encourage the patient to use hand hygiene. Where access to handwashing facilities is prohibitive in the home, then handwipes must be used, followed by alcohol hand sanitiser.

PPE Minimum PPE for healthcare workers when in contact with infectious GAS patients consists of disposable gloves and aprons. A fluid repellent surgical mask and or eye protection is not required unless there is a risk of exposure to droplets i.e. change of dressings, care of necrotising fasciitis and procedures likely to generate droplets. In the event of an outbreak, it may be necessary to wear a plastic long sleeved gown. Health care workers with breaks in their skin must cover lesions with a waterproof dressing. If they become infected, they must inform their manager, Medigold or seek help from their own GP.

Decontamination of Equipment Medical equipment that is designated as reusable and used in the community setting must be managed and decontaminated following the designated guidance in the decontamination of medical equipment policy IPPOL09. i.e. decontaminated after each use and weekly in the designated decontamination areas. In the event of an outbreak this will be increased to daily cleaning. Car boots should be cleaned weekly and monitored by senior staff. When a case is known or in the event of an outbreak or period of increased incidence the monitoring of decontamination standards will be reviewed with relevant service managers and outbreak group to agree whether an increase in audit frequency is required. Increased auditing of decontamination of equipment is performed via the ward app and any variances actioned. If possible and where a case is confirmed with GAS any reusable equipment should be designated for that patient to prevent potential spread. If this is not possible, guidance must be sought from the Infection Prevention team prior to any re-use on another patient.

Community Visits Community staff should, if possible, visit a known case of GAS last on morning/afternoon list and staff should avoid taking non-essential equipment into the patient’s home. Visits to care/residential homes where multiple residents are seen, Page 12 of 21


GAS cases should be seen at the end of the visit list as per keeping with efforts to maintain isolation measures and preventing risk of onward transmission. In the instance where multiple weekly visits are required to the same care home/ residence a cohort of staff should be implemented until the wounds are healed or treated and the cases no longer infection risk. Where multiple wounds are being managed an increase in screening amongst caseload maybe required and will be directed by IPCT in consultation with Consultant Microbiologist and local health protection Team. Community staff must ensure hand washing and use of a hand sanitizing gel takes place before and on completion of the visit. (See Hand Hygiene Policy). During an outbreak staff may be asked to wash their hands and length of forearms up to their elbows.

Uniform All staff should be bare below the elbows on visiting patients. Outdoor clothing such as coats and cardigans should be removed prior to entering patient’s home. A clean uniform must be worn each day. Uniforms must be washed at highest temperature for that material according to the fabric label

8. Management of cases Reporting One Case All cases of iGAS are notifiable to local Health protection team. Within Provide CIC cases of iGAS will have been confirmed from the local laboratory. For all cases of GAS and iGAS that nurses or healthcare workers become of aware they must inform the infection Prevention team as a priority and complete the Healthcare associated Infection Alert form on the intranet and send to mailto:provide.infectionpreventionteam@nhs.net

Reporting Two Cases Where two cases are identified linked by person or place prompt reporting to the IPCT must be undertaken (these cases will usually be within a month of each other, but the interval may extend to six months where cases detected are due to typing of isolates over an extended period). This also applies when there is a case of iGAS and a case of GAS. If an outbreak is detected or a cluster of cases the IPCT team must be informed and incidence notified to local Health protection team as per IPPOL16 Management and Control of an Outbreak of infection The Infection prevention team will undertake this in consultation with Consultant Microbiologist and directorate during working hours. Outside these hours the notification will be undertaken by assistant director. During an outbreak it may be considered necessary to cohort nursing teams on a caseload or working in a team. All advice will be taken in consultation with the local Health Protection Team. An outbreak must have a datix completed, and patients GP(s) or clinician(s) informed. Follow the outbreak policy IPPOL16 Management and Control of an Outbreak of Infection.

Page 13 of 21


Contacts On notification of iGAS the local Health Protection team will investigate all close contacts, and this may include Provide CIC Health care workers that have cared for a patient in the home or nursing/residential setting. Where this is required, line managers will need to ensure they can provide a contact list of staff that fulfil the criteria requested by the local health protection team.

Prophylaxis All prophylaxis and treatment of staff who have either infection or carriage must be discussed with the local Health Protection team and Consultant Microbiologist and if involved, IPC staff at the Integrated Care System Where Occupational Health has agreed to treat and screen staff, line managers will be informed by the IPCT.

9. Training All staff will continue to receive training in SICP as part of induction and mandatory training requirements. Staff may receive specific training in relation to this procedure where it is identified as part of a post outbreak or incident requirement, or as an individual appraisal development need.

10. References •

NHS England (2023) IPC A to Z of pathogens resource (draft) https://www.england.nhs.uk/publication/national-infection-prevention-andcontrol/

•

UKHSA (2023) UK guidelines for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings Invasive group A streptococcal disease: managing close contacts in community settings - GOV.UK (www.gov.uk)

•

UKHSA (2023) Group A Streptococcus: Information and guidance on group A streptococcal infections Group A Streptococcus - GOV.UK (www.gov.uk)

•

UKHSA (2021) Report, Invasive group A streptococcal outbreaks associated with community health services delivered at home, January 2018 to September 2019 Invasive group A streptococcal outbreaks: home healthcare - GOV.UK

•

Steer JA, Lamagni TL, Healy B, Morgan M, Dryden M, Rao B and others. ‘Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK.’ Journal of Infection 2012: volume 64, number 1 Accessed via link Group A Streptococcus - GOV.UK Page 14 of 21


Appendix 1: Patient information Leaflet Information for Patient’s: Group A Streptococcus UKHSA Group A Strep – What you need to know – UK Health Security Agency Group A streptococcus (GAS), also referred to as Strep A is a common bacterium. Lots of us carry it in our throats and on our skin and it doesn’t always result in illness. However, GAS does cause a number of infections, some mild and some more serious. Milder infections caused by GAS include scarlet fever, impetigo, cellulitis and pharyngitis. These can be easily treated with antibiotics.

How is it spread? GAS is spread by close contact with an infected person and can be passed on through coughs and sneezes or from a wound. As the bacteria can colonise the throat, skin and anogenital tract, it can be spread by close contact between individuals, through respiratory particles and direct skin contact. It can also be transmitted environmentally, for example through contact with contaminated objects, such as towels or bedding, or ingestion of food prepared by someone with the infection. Some people can have the bacteria present in their body without feeling unwell or showing any symptoms of infections and while they can pass it on, the risk of spread is much greater when a person is unwell.

Which infections does GAS cause? GAS causes infections in the skin, soft tissue and respiratory tract. It’s responsible for infections such as tonsillitis, pharyngitis, scarlet fever, impetigo and cellulitis among others. While infections like these can be unpleasant, they rarely become serious. When treated with antibiotics, an unwell person with a mild illness like tonsilitis stops being contagious around 24 hours after starting their medication.

What is invasive group A strep? The most serious infections linked to GAS come from invasive group A strep, known as iGAS. This can happen when a person has sores or open wounds that allow the bacteria to get into the tissue, breaches in their respiratory tract after a viral illness, or in a person who has a health condition that decreases their immunity to infection. When the immune system is compromised, a person is more vulnerable to invasive disease.

Page 15 of 21


How can we stop infections from spreading? Good hand and respiratory hygiene are important for stopping the spread of many bugs. By teaching your child how to wash their hands properly with soap and warm water for 20 seconds, using a tissue to catch coughs and sneezes, and keeping away from others when feeling unwell, they will be able to reduce the risk of picking up, or spreading, infections

Who needs to take antibiotics? Antibiotics are not routinely recommended as a preventative treatment and should only be taken in confirmed cases of scarlet fever or another GAS infection, or in certain circumstances where Health Protection Teams recommend their wider use. Information taken from Group A Strep – What you need to know – UK Health Security Agency More information on GAS can be found on the NHS website Strep A - NHS

Page 16 of 21


Appendix 2: Patient information Leaflet

Page 17 of 21


EQUALITY IMPACT ASSESSMENT TEMPLATE Stage 1: ‘Screening’ The Equality Impact Assessment needs to be completed so that any decisions made are compliant with the aims of the Public Sector Equality Duty – and that any adverse impact for any protected characteristics are identified and resolved. Policy Title

Management of Group A Streptococcus in Community Setting Provide a brief summary (bullet points) of the aims of the Policy

• • •

Identify Signs and symptoms of Group A Streptococcus infection Implement Infection precautions required to manage staff and patient safety from risk from Group A Streptococcus Escalate risk of transmission or cases of infection from the community settings per outbreak policy

EQIA Assessor Name and Job Title

Date of Assessment

Lucy Ellis Specialist Infection Prevention 8/9/2026 and Control Nurse This stage establishes whether a proposed initiative will have an impact from an equality perspective on any particular group of people or community or whether it is “equality neutral” (i.e. have no effect either positive or negative)

Q1. Will this policy affect one of the following groups more or less favourably than another?

Group

More

Less

Neutral

Details If more or less, explain impact and any valid legal and/or justifiable exception. Include the source of any evidence

Age Consider impact and detail across age ranges on old and younger people. This can include safeguarding, consent and child welfare Disability Consider and detail impact on attitudinal, physical, and social barriers. Sex Consider and detail impact on men and women (potential to link to carers) Gender reassignment (including transgender) Consider and detail impact on transgender and transsexual people. This can include issues such as privacy of data and harassment. Pregnancy and maternity Consider and detail impact on working arrangements, part-time working, infant caring responsibilities.

Neutral

Neutral Neutral Neutral

Neutral

Page 18 of 21


Race Consider and detail impact on different ethnic groups, nationalities, Roma gypsies, Irish travellers, language and communication barriers. Religion or belief Consider and detail impact on people with different religions, beliefs or no belief. Sexual orientation Consider and detail impact on heterosexual people as well as lesbian, gay and bi-sexual people Carers Consider and detail impact on part-time working, shift-patterns, general caring responsibilities Other identified groups Consider and detail on different socioeconomic groups, area inequality, income, resident status (migrants) and other groups experiencing disadvantage and barriers to access.

Assessed Impact overall

  

Positive X Neutral Negative

Neutral

Neutral

Neutral

Neutral

Neutral

Is the impact of the initiative – whether positive or negative significant enough to warrant a more detailed Stage 2 assessment?

 

Yes X No

Guidelines: Things to consider Equality impact assessments at Provide take account of relevant equality legislation and include age, (i.e. young and old,); race and ethnicity, gender, disability, religion and faith, and sexual orientation. The initiative may have a positive, negative or neutral impact, i.e. have no particular effect on the group/community. Where a negative (i.e. adverse) impact is identified, it may be appropriate to make a more detailed EIA (see Stage 2), or as important, take early action to redress this – e.g. by abandoning or modifying the initiative. NB: If the initiative contravenes equality legislation, it must be abandoned or modified. Where an initiative has a positive impact on groups/community relations, the EIA should make this explicit, to enable the outcomes to be monitored over its lifespan. Where there is a positive impact on particular groups does this mean there could be an adverse impact on others, and if so, can this be justified? - e.g. are there other existing or planned initiatives which redress this? It may not be possible to provide detailed answers to some of these questions at the start of the initiative. The EIA may identify a lack of relevant data, and that data-gathering is a specific action required to inform the initiative as it develops, and also to form part of a continuing evaluation and review process. It is envisaged that it will be relatively rare for full impact assessments to be carried out at Provide. Usually, where there are particular problems identified in the screening stage, it is envisaged that the approach will be amended at this stage, and/or setting up a monitoring/evaluation system to review a policy’s impact over time.

Page 19 of 21


EQUALITY IMPACT ASSESSMENT TEMPLATE Stage 2 To be used where the ‘screening phase has identified a substantial problem/concern) This stage examines the initiative in more detail in order to obtain further information where required about its potential adverse or positive impact from an equality perspective. It will help inform whether any action needs to be taken and may form part of a continuing assessment framework as the initiative develops. Policy/ Project Title

EIA Assessor Name and Job Title

Date of Assessment

EIA Review by Chief Officer name and Job Title

Date Of Review

Outcome of Chief Officer Review Q1. What data/information is there on the target beneficiary groups/communities?

Are any of these groups under- or over-represented? Do they have access to the same resources?

   

Yes No Yes No

 

Yes No

What are your sources of data and are there any gaps?

Q2. Is there a potential for this initiative to have a positive impact, such as tackling discrimination, promoting equality of opportunity and good community relations? If yes, how? Which are the main groups it will have an impact on?

Q3. Will the initiative have an adverse impact on any particular  Yes group or community/community relations?  No If yes, in what way? Will the impact be different for different groups – e.g. men and women?

Q4. Has there been consultation/is consultation planned with  Yes stakeholders/ beneficiaries/ staff who will be affected by the  No initiative? Summarise (bullet points) any important issues arising from the consultation

Page 20 of 21


Q5. Given your answers to the previous questions, how will your plans be revised to reduce/eliminate negative impact or enhance positive impact?

Are there specific factors which need to be taken into account?

 

Yes No

Q6. How will the initiative continue to be monitored and evaluated, including its impact on particular groups/ improving community relations? Where appropriate, identify any additional data that will be required

Guidelines: Things to consider An initiative may have a positive impact on some sectors of the community but leave others excluded or feeling they are excluded. Consideration should be given to how this can be tackled or minimised. It is important to ensure that relevant groups/communities are identified who should be consulted. This may require taking positive action to engage with those groups who are traditionally less likely to respond to consultations, and could form a specific part of the initiative. The consultation process should form a meaningful part of the initiative as it develops, and help inform any future action. If the EIA shows an adverse impact, is this because it contravenes any equality legislation? If so, the initiative must be modified or abandoned. There may be another way to meet the objective(s) of the initiative.

Page 21 of 21


Turn static files into dynamic content formats.

Create a flipbook
IPPOL30 Management of Group A Streptococcus infection in Community Settings V3 by Provide Community - Issuu